Skip to main content

Neurological Emergencies in the Immunocompromised Population

  • Chapter
  • First Online:
Emergencies in Neurology

Abstract

Neurological emergencies are a significant source of morbidity and mortality in immunocompromised patients. Immunodeficiency can be attributed to congenital and acquired causes. Congenital immunodeficiencies can either be combined with involvement of both cellular and humoral immunity or restricted to impairment of either type. Common combined immunodeficiency syndromes include ataxia telangiectasia, Wiskott Aldrich syndrome, and DiGeorge syndrome whereas X linked agammaglobulinemia and common variable immunodeficiency are characterized by isolated impaired humoral immunity. As opposed to rare patients with congenital immunodeficiencies, acquired immunodeficiencies are much more common. Acquired immunodeficiency is seen in HIV patients, diabetics, and in various patients treated with immunosuppressive, cytotoxic, and antirejection medications (e.g., transplant recipients, patients with autoimmune disorders, and cancer). These people are at increased risk of various neurologic emergencies including opportunistic CNS infections, posterior reversible encephalopathy syndrome (PRES), immune reconstitution inflammatory syndrome (IRIS), epilepsy, and stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Linden PK. Approach to the immunocompromised host with infection in the intensive care unit. Infect Dis Clin N Am. 2009;23(3):535–56.

    Article  Google Scholar 

  2. Sakhuja V, Sud K, Kalra OP, D’Cruz S, Kohli HS, Jha V, et al. Central nervous system complications in renal transplant recipients in a tropical environment. J Neurol Sci. 2001;183(1):89–93.

    Article  CAS  PubMed  Google Scholar 

  3. Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis. 2006;42(1):115–25.

    Article  PubMed  Google Scholar 

  4. Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl. 2011;17(Suppl 3):S34–7.

    Article  PubMed  Google Scholar 

  5. van de Beek D, Kremers W, Daly RC, Edwards BS, Clavell AL, McGregor CG, et al. Effect of neurologic complications on outcome after heart transplant. Arch Neurol. 2008;65(2):226–31.

    PubMed  Google Scholar 

  6. Zivkovic SA, Abdel-Hamid H. Neurologic manifestations of transplant complications. Neurol Clin. 2010;28(1):235–51.

    Article  PubMed  Google Scholar 

  7. Whitley RJ. Herpes simplex virus infections of the central nervous system. Continuum. 2015;21(6, Neuroinfectious Disease):1704–13.

    PubMed  Google Scholar 

  8. Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bonstrup M, Havemeister S, et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology. 2013;81(18):1637–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nagel MA, Gilden D. Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol. 2014;27(3):356–60.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yango AF, Fischbach BV, Levy M, Chandrakantan A, Tan V, Spak C, et al. West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic. Transplantation. 2014;97(9):953–7.

    PubMed  Google Scholar 

  11. Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012;366(20):1870–80.

    Article  CAS  PubMed  Google Scholar 

  12. Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis. 2009;48(10):1459–66.

    Article  PubMed  Google Scholar 

  13. Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M, Progressive Multifocal Leukeoncephalopathy C. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015;8(6):255–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS. 2008;22(14):1759–67.

    Article  PubMed  CAS  Google Scholar 

  15. Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev. 2000;23(4):175–204; discussion 5.

    Article  CAS  PubMed  Google Scholar 

  16. Pradilla G, Ardila GP, Hsu W, Rigamonti D. Epidural abscesses of the CNS. Lancet Neurol. 2009;8(3):292–300.

    Article  PubMed  Google Scholar 

  17. Panackal AA, Williamson PR. Fungal infections of the central nervous system. Continuum. 2015;21(6, Neuroinfectious Disease):1662–78.

    PubMed  Google Scholar 

  18. Pustavoitau A, Bhardwaj A, Stevens R. Neurological complications of transplantation. J Intensive Care Med. 2011;26(4):209–22.

    Article  PubMed  Google Scholar 

  19. Mendez O, Kanal E, Abu-Elmagd KM, McFadden K, Thomas S, Bond G, et al. Granulomatous amebic encephalitis in a multivisceral transplant recipient. Eur J Neurol. 2006;13(3):292–5.

    Article  CAS  PubMed  Google Scholar 

  20. Bahr N, Boulware DR, Marais S, Scriven J, Wilkinson RJ, Meintjes G. Central nervous system immune reconstitution inflammatory syndrome. Curr Infect Dis Rep. 2013;15(6):583–93.

    Article  PubMed  Google Scholar 

  21. Clifford DB. Neurological immune reconstitution inflammatory response: riding the tide of immune recovery. Curr Opin Neurol. 2015;28(3):295–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65(2):205–10.

    Article  PubMed  Google Scholar 

  23. Bodkin CL, Eidelman BH. Sirolimus-induced posterior reversible encephalopathy. Neurology. 2007;68(23):2039–40.

    Article  PubMed  Google Scholar 

  24. Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol. 1996;40(4):575–80.

    Article  CAS  PubMed  Google Scholar 

  25. Lamy C, Oppenheim C, Meder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004;14(2):89–96.

    Article  CAS  PubMed  Google Scholar 

  26. Guarino M, Benito-Leon J, Decruyenaere J, Schmutzhard E, Weissenborn K, Stracciari A. EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol. 2006;13(1):2–9.

    Article  CAS  PubMed  Google Scholar 

  27. Graff-Radford J, Fugate JE, Kaufmann TJ, Mandrekar JN, Rabinstein AA. Clinical and radiologic correlations of central pontine myelinolysis syndrome. Mayo Clin Proc. 2011;86(11):1063–7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chow FC. HIV infection, vascular disease, and stroke. Semin Neurol. 2014;34(1):35–46.

    Article  PubMed  Google Scholar 

  29. Jarquin-Valdivia AA, Wijdicks EF, McGregor C. Neurologic complications following heart transplantation in the modern era: decreased incidence, but postoperative stroke remains prevalent. Transplant Proc. 1999;31(5):2161–2.

    Article  CAS  PubMed  Google Scholar 

  30. Oliveras A, Roquer J, Puig JM, Rodriguez A, Mir M, Orfila MA, et al. Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transpl. 2003;17(1):1–8.

    Article  Google Scholar 

  31. Shepard PW, St Louis EK. Seizure treatment in transplant patients. Curr Treat Options Neurol. 2012;14(4):332–47.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saša A. Živković .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ojha, A., Živković, S.A. (2019). Neurological Emergencies in the Immunocompromised Population. In: Singh, M., Bhatia, R. (eds) Emergencies in Neurology . Springer, Singapore. https://doi.org/10.1007/978-981-13-7381-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7381-7_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7379-4

  • Online ISBN: 978-981-13-7381-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics